Meropenem 500 mg IV Infusion Time
For a 500 mg intravenous dose of meropenem, administer over 15-30 minutes as a standard infusion, or over 3 minutes to 5 minutes as a bolus injection. 1
Standard FDA-Approved Administration
The FDA label clearly specifies that meropenem 500 mg should be administered by:
- Intravenous infusion over approximately 15-30 minutes (standard method)
- Intravenous bolus injection over approximately 3-5 minutes (alternative method for doses up to 1 gram) 1
Clinical Context: When to Consider Prolonged Infusion
While the standard infusion time is 15-30 minutes, prolonged or continuous infusions should be considered in specific high-risk scenarios to optimize pharmacodynamic target attainment 2:
Indications for Extended Infusion (3 hours):
Critically ill patients with septic shock or high severity scores - to improve clinical cure rates 2
Infections caused by organisms with high MIC values (>2 mg/L for most pathogens):
Patients with augmented renal clearance - who frequently fail to achieve pharmacodynamic targets with standard dosing 3, 4, 5
Carbapenem-resistant organisms - where extended infusion of meropenem (3 hours) is specifically recommended when MIC ≥8 mg/L 6
Evidence for Prolonged Infusion:
Research demonstrates that 3-hour infusions of 500 mg every 6-8 hours maintain 100% time above MIC for pathogens with MIC ≤8 mg/L 7, compared to standard infusions which may fail to achieve adequate exposure, particularly in critically ill patients 8, 4.
Practical Algorithm
Use standard 15-30 minute infusion when:
- Non-critically ill patients
- Susceptible organisms (MIC ≤1 mg/L)
- Normal renal function
Use 3-hour extended infusion when:
- Critically ill/septic shock patients
- Organisms with MIC 2-8 mg/L
- Augmented renal clearance present
- Carbapenem-resistant organisms (per guideline recommendation) 6
Important Caveats
- The 500 mg dose itself may be inadequate for serious infections; 1 gram every 8 hours is recommended for complicated intra-abdominal infections and Pseudomonas infections 1
- Pediatric patients <3 months require 30-minute infusions specifically 1
- Bolus administration (3-5 minutes) is FDA-approved but provides suboptimal pharmacodynamics in critically ill patients and should be reserved for stable, non-critically ill patients with highly susceptible organisms